Skip to search formSkip to main contentSkip to account menu

ankaferd blood stopper

Known as: ankaferd BloodStopper 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Plant Extracts

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
EFFECTS OF FOLK MEDICINAL PLANT EXTRACT ANKAFERD BLOOD STOPPER ON BURN WOUND HEALING
Objective: Ankaferd Blood Stopper (ABS), a mixture of five medicinal plant extracts, has been used historically as a haemostatic… 
2013
2013
Ankaferd blood stopper in episiotomy repair.
BACKGROUND AND OBJECTIVE Ankaferd blood stopper (ABS) is a new hemostatic agent that is licensed for external hemorrhages. ABS… 
2012
2012
Evaluation of cytotoxicity of a new hemostatic agent Ankaferd Blood Stopper® using different assays
The aim of this study is to investigate the effects of the Ankaferd Blood Stopper® (ABS), on cell viability, cytotoxicity, and… 
Review
2011
Review
2011
Ankaferd hemostat in the management of gastrointestinal hemorrhages.
Gastrointestinal (GI) bleeding refers to any hemorrhage ascribed to the pathologies of the gastrointestinal tract, extending from… 
2010
2010
Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage.
OBJECTIVE To investigate the effect of Ankaferd Blood Stopper (ABS), on renal tubular apoptosis and on expressions of endothelial… 
2010
2010
Ability of the ankaferd blood stopper® to prevent parenchymal bleeding in an experimental hepatic trauma model.
UNLABELLED Hepatic parenchymal bleeding (HPB) is a major problem following both trauma and elective hepatic procedures. The… 
2010
2010
Does intraabdominal use of Ankaferd Blood Stopper cause increased intraperitoneal adhesions?
BACKGROUND The aim of this study was to investigate whether intraabdominal Ankaferd Blood Stopper (ABS) causes increased… 
Review
2010
Review
2010
First Clinical Experience of Ankaferd BloodStopper as a Hemostatic Agent in Partial Nephrectomy
2009
2009
Effectiveness of Ankaferd blood stopper in the topical control of active bleeding due to cutaneous-subcutaneous incisions.
OBJECTIVE To assess the effectiveness of Ankaferd blood stopper (ABS) in the topical control of bleeding due to cutaneous… 
2009
2009
Haemostatic role and histopathological effects of a new haemostatic agent in a rat bladder haemorrhage model: an experimental trial
To investigate the haemostatic efficacy and histopathological effects of a new haemostatic agent, Ankaferd BloodStopper® (ABS… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)